When facing colon cancer, getting the right diagnosis and treatment plan can change everything. Memorial Sloan Kettering Cancer Center (MSKCC) is one of the world’s top destinations for advanced cancer care, offering global patients life-saving expertise through remote second opinions. This article explores how international patients—especially those whose local treatments have reached a dead end—can access MSKCC’s leading oncologists through Medebound HEALTH’s seamless coord

For many international patients, accessing world-class cancer expertise once required traveling overseas, a journey often limited by cost, distance, and language barriers. Today, platforms like Medebound HEALTH make it possible to obtain a Sloan Kettering second opinion online, connecting patients directly with leading U.S. oncologists from the comfort of their homes.

This article highlights key 2025 advances in pancreatic cancer treatment, including new FDA-approved drugs, targeted therapies, and AI-driven care. It features the real story of Mei Ling, a Stage III patient who accessed a U.S. clinical trial through Medebound HEALTH and achieved curative surgery.